Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis - Collin, C.; Davies, P.; Mutiboko, I. K.; Ratcliffe, S. (European journal of neurology, 2007)
Keywords: Administration, Oral; Adult; Cannabidiol - administration & dosage; Cannabidiol - adverse effects; Cannabinoids - administration & dosage; Cannabinoids - adverse effects; cannabis-based medicine; Central Nervous System - drug effects; Central Nervous System - physiopathology; Double-Blind Method; Dronabinol - administration & dosage; Dronabinol - adverse effects; Female; Humans; Male; Middle Aged; multiple sclerosis; Multiple Sclerosis - complications; Multiple Sclerosis - drug therapy; Multiple Sclerosis - physiopathology; Muscle Spasticity - drug therapy; Muscle Spasticity - etiology; Muscle Spasticity - physiopathology; Placebos; Plant Extracts - administration & dosage; Plant Extracts - adverse effects; Sativex; spasticity; Treatment Outcome